Darroch Medical Solutions

What Darroch Medical Solutions does

Darroch Medical Solutions, Inc. is a San Diego-based medical technology company founded in 2018 by three University of San Diego engineers to address the absence of continuous patient monitoring in non-ICU hospital settings. The company develops a vertically integrated platform that autonomously connects to bedside medical devices (vitals monitors, IV pumps, bed sensors, TCMs) through proprietary hardware interfaces, capturing high-frequency physiological signals at intervals up to once per second. These multi-device streams are harmonized into time-synchronized patient profiles and surfaced to clinicians via the Lumori mobile application, with the underlying data feeding the Beat Intelligence Platform for predictive analytics and algorithm development. The company sells primarily into acute care hospitals (medical-surgical and step-down units) and, pending FDA clearance, skilled nursing facilities via its Wearable Monitor.

The product portfolio comprises four integrated components: the Beat Analytics System (core data aggregation platform), the Lumori App (mobile clinical interface delivering device data within seconds of capture), the Wearable Monitor (outpatient vital signs monitor aggregating pulse rate, SPO2, respiratory rate, skin temperature, and heart rate variability at one-minute intervals), and the Beat Intelligence Platform (de-identified data warehouse for research and predictive AI development). The company has published peer-reviewed research on ML models for sepsis and hypotension anticipation, and has produced case studies at named health systems including Scripps Health, University of Toledo Medical Center, and Kaweah Health Medical Center on bed exit and pneumonia adverse event prevention. Management includes co-founders Anthony Shao (CEO), Colby Bishop (CTO), and Jacques (Jack) Yeager (CMO), with Subramanian (Venkat) Shastri as Chairman and board members Jay Stead and Gareth De Sanctis.

Darroch generates revenue through a combination of hardware installation and integration (Beat Analytics System), ongoing software subscription access, hardware sales of the Wearable Monitor to outpatient facilities, and potential licensing/royalty arrangements for research collaborations on the Beat Intelligence Platform. Pricing is quote-based and not publicly disclosed; the go-to-market is direct enterprise sales targeting hospital C-suite, clinical leadership, and nursing administration. The company is currently seeking both pilot partners and outside investors, with no funding rounds disclosed in the source material. Geographic scope is limited to the United States, headcount is 1-10 employees, and the Wearable Monitor remains labeled Investigational Use Only pending FDA clearance.

Name

Darroch Medical Solutions

Legal name

Darroch Medical Solutions, Inc.

Website

https://darrochmedical.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Darroch Medical Solutions develops a vertically integrated patient monitoring platform that autonomously captures high-frequency bedside device data and applies predictive AI to anticipate adverse events in non-ICU hospital settings, serving acute care hospitals, skilled nursing facilities, and clinical researchers in the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Beat Analytics System: Hardware and software platform sold to hospitals for continuous patient monitoring. Revenue from system installation, device integration hardware, and ongoing software access. Potential 10x ROI claimed for care facilities.
2. Wearable Monitor: Wearable medical device sold to outpatient facilities (skilled nursing facilities) for continuous patient monitoring outside hospital settings.
3. Beat Intelligence Platform Research Services: Research-grade data platform supporting algorithm development and patient safety initiatives for hospitals and researchers. Collaboration model with leading hospitals for predictive research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Darroch Medical Solutions develops and sells a vertically integrated continuous patient monitoring platform comprising the Beat Analytics System (hardware-connected, high-frequency bedside data aggregation up to once per second), the Lumori mobile application for clinician-facing real-time data, a wearable outpatient vital-signs monitor, and the Beat Intelligence Platform AI/data warehouse. The offering targets adverse-event anticipation in non-ICU hospital wards, skilled nursing facilities, and outpatient settings, with the wearable currently labeled for Investigational Use Only pending FDA clearance.

Product overview

Darroch Medical Solutions offers a vertically integrated healthcare monitoring platform consisting of the Beat Analytics System as the core data aggregation platform, paired with the Lumori App for mobile clinical presentation and the Wearable Monitor for outpatient settings. The Beat Intelligence Platform serves as the AI/data foundation layer, enabling advanced analytics and algorithm development. All products work together to capture high-frequency bedside data, present actionable insights to clinicians, and support predictive AI research.

Differentiator

Problem solved

Functional benefit

Brands

• Beat Analytics System: A continuous data platform that connects directly to medical devices, capturing high-frequency signals and metadata to create a unified patient profile. Ingests device data up to every second, creating a holistic and synchronized view of the patient.
• Lumori
• Beat Intelligence Platform

Products and services

• Beat Analytics System A continuous bedside data platform that autonomously connects to medical devices and captures high-frequency signals (up to once per second) and metadata, integrating data from vitals, IVs, bed sensors, and TCMs through special hardware connections into a unified, time-synchronized patient profile for acute care hospitals' non-ICU wards.
• Lumori App A secure mobile application that delivers synchronized, high-frequency multi-device data to clinicians within seconds of capture, presenting visual trends, correlations across devices, and out-of-range highlights to support physicians and nurses in non-ICU step-down and medical-surgical units.
• Wearable Monitor A wearable vital-signs monitor for outpatient and skilled nursing facilities that aggregates pulse rate, SpO2, respiratory rate, skin temperature, and heart rate variability every minute, presenting data via the Lumori App to support remote monitoring of medically complex residents and help prevent hospital readmissions.
• Beat Intelligence Platform A research-grade AI platform and data warehouse that leverages de-identified, high-frequency, time-synchronized physiological datasets (paired with demographic and pharmacologic data) to support advanced research, algorithm development, and patient safety initiatives for hospitals and healthcare AI researchers.

Quantifiable outcome

• Up to 60% of acute care adverse events can be prevented with improved monitoring and Early Warning Systems
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• EarlySense: EarlySense offers contact-free continuous patient monitoring for non-ICU hospital wards and skilled nursing facilities, capturing heart and respiratory rate via a bed sensor. It is the closest direct competitor to Darroch's Beat Analytics System in terms of continuous non-ICU monitoring, though EarlySense lacks Darroch's multi-device AI analytics and Lumori-style mobile interface.
• Biofourmis: Biofourmis combines wearable-based remote patient monitoring with AI-driven predictive analytics for early detection of clinical deterioration. Its focus on RPM plus analytics parallels Darroch's combination of bedside device integration with the Beat Intelligence Platform.
• Hicuity Health: Hicuity Health provides virtual nursing and tele-ICU/critical-care monitoring services using continuous bedside data delivered to remote clinicians — directly comparable to Darroch's Lumori App value proposition of mobile clinician visibility into continuous device data.

Emerging players

• Sotera Wireless (ViSi Mobile): Sotera Wireless developed the ViSi Mobile wearable for continuous vital-sign monitoring on general hospital wards, a comparable non-ICU continuous-monitoring use case to Darroch's wearable and Beat Analytics System, though Sotera has had a more uneven commercial trajectory.
• Vivify Health: Vivify Health provides a remote patient monitoring platform with mobile interfaces and condition-specific care pathways, similar to Darroch's wearables-plus-mobile-presentation model for outpatient/SNF use cases.

Broad incumbents

• Masimo: Masimo is a broad incumbent in patient monitoring with deep hospital relationships, particularly in pulse oximetry and continuous vitals. Its installed base and FDA-cleared monitoring hardware represent the competitive floor that Darroch must displace in non-ICU monitoring.
• Philips Patient Monitoring: Philips offers the IntelliVue and similar continuous patient monitoring systems deployed across U.S. hospitals, including non-ICU wards. As a broad incumbent, Philips can bundle monitoring hardware, EMR integration, and analytics — a strategic threat to Darroch's TAM.
• GE HealthCare Patient Monitoring: GE HealthCare sells CARESCAPE and other continuous monitoring solutions widely deployed in U.S. hospitals. Its scale, salesforce, and existing integrations with hospital IT systems position it as a primary incumbent competitor in Darroch's acute-care target market.
• Medtronic (Patient Monitoring): Medtronic offers continuous patient monitoring solutions including the VitalSync platform for non-ICU settings. Its global salesforce and ICU/monitoring installed base make it a relevant broad-incumbent comparable in Darroch's target acute-care segment.
• Mindray: Mindray is a global medical device manufacturer with continuous patient monitoring systems used in both hospital wards and skilled nursing facilities. It is a relevant broad-incumbent comparable particularly for Darroch's Wearable Monitor / SNF expansion plans.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/darroch-medical-solutions-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Darroch Medical Solutions